Spok initiated with a Neutral at B. Riley

B. Riley analyst Kyle Bauser last night initiated coverage of Spok with a Neutral rating and $15 price target. Spok is a healthcare IT company that provides communications capabilities to leading hospitals in the U.S., the analyst tells investors in a research note. The firm says that if the company were to return to adjusted EBITDA growth as a result of reduced pager erosion, higher software sales growth, and international expansion, it would likely become more constructive on the name. now, Riley awaits margin expansion and remains on the sidelines.